M. Decatris

742 total citations
19 papers, 505 citations indexed

About

M. Decatris is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, M. Decatris has authored 19 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in M. Decatris's work include Cancer Treatment and Pharmacology (4 papers), HER2/EGFR in Cancer Research (3 papers) and CAR-T cell therapy research (2 papers). M. Decatris is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), HER2/EGFR in Cancer Research (3 papers) and CAR-T cell therapy research (2 papers). M. Decatris collaborates with scholars based in United Kingdom, Cyprus and Ireland. M. Decatris's co-authors include Santhanam Sundar, Kenneth J. O’Byrne, Ricky A. Sharma, Anne Thomas, Sandy Beare, William P. Steward, C. Arun, N.J.M. London, David Hemingway and Richard Welch and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

M. Decatris

19 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Decatris United Kingdom 12 240 146 116 90 72 19 505
E. Joosens Belgium 11 258 1.1× 133 0.9× 173 1.5× 102 1.1× 72 1.0× 26 587
Katsuyuki Kunieda Japan 13 288 1.2× 198 1.4× 164 1.4× 164 1.8× 79 1.1× 83 697
Chris R. Garrett United States 12 305 1.3× 382 2.6× 214 1.8× 98 1.1× 70 1.0× 43 757
Masaharu Ohgaki Japan 13 152 0.6× 180 1.2× 122 1.1× 145 1.6× 64 0.9× 28 494
Marianna Silletta Italy 14 224 0.9× 157 1.1× 214 1.8× 63 0.7× 87 1.2× 42 613
Shigehiko Nishimura Japan 13 257 1.1× 182 1.2× 128 1.1× 149 1.7× 60 0.8× 50 617
Joan Sorich United States 13 439 1.8× 330 2.3× 97 0.8× 203 2.3× 63 0.9× 31 759
Enrique Grande Pulido Spain 11 220 0.9× 229 1.6× 93 0.8× 70 0.8× 100 1.4× 35 530
Sashidhar Yeluri United Kingdom 10 107 0.4× 189 1.3× 61 0.5× 142 1.6× 155 2.2× 24 534
Thierry Nguyen France 15 281 1.2× 93 0.6× 203 1.8× 159 1.8× 95 1.3× 40 613

Countries citing papers authored by M. Decatris

Since Specialization
Citations

This map shows the geographic impact of M. Decatris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Decatris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Decatris more than expected).

Fields of papers citing papers by M. Decatris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Decatris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Decatris. The network helps show where M. Decatris may publish in the future.

Co-authorship network of co-authors of M. Decatris

This figure shows the co-authorship network connecting the top 25 collaborators of M. Decatris. A scholar is included among the top collaborators of M. Decatris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Decatris. M. Decatris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Decatris, M., Mark P. Hayes, Philip Ryan, et al.. (2021). Programmed death-ligand (PD-L1) expression and tissue heterogeneity in advanced non-small cell lung cancer (NSCLC). Lung Cancer. 156. S29–S30. 1 indexed citations
2.
Decatris, M., Philippe Tanière, Mark P. Hayes, et al.. (2018). P3.01-22 An Exploratory Analysis of PD-L1 Expression and Smoking History in a Cohort of Advanced Non-Small Cell Lung Cancer Patients. Journal of Thoracic Oncology. 13(10). S875–S876. 1 indexed citations
3.
Decatris, M. & Kenneth J. O’Byrne. (2016). Immune Checkpoint Inhibitors as First-Line and Salvage Therapy for Advanced Non-Small-Cell Lung Cancer. Future Oncology. 12(15). 1805–1822. 7 indexed citations
4.
Decatris, M., et al.. (2014). Melanoma of the gallbladder: appropriate surgical management and review of the literature. Clinical Case Reports. 2(6). 313–318. 18 indexed citations
5.
Reichardt, Peter, Jean‐Yves Blay, I. Boukovinas, et al.. (2012). Adjuvant therapy in primary GIST: state-of-the-art. Annals of Oncology. 23(11). 2776–2781. 50 indexed citations
6.
Charalambous, Haris, M. Decatris, Dimitrios Vomvas, & Petros Kitsios. (2011). 7121 POSTER Bladder Preservation a Valid Option for Patients With Muscle Invasive Bladder Cancer – Single Centre Experience. European Journal of Cancer. 47. S510–S511. 1 indexed citations
7.
Chandiramani, Manju, et al.. (2006). Dermatomyositis as a Paraneoplastic Syndrome in Carcinosarcoma of Uterine Origin. Clinical Oncology. 18(9). 641–648. 13 indexed citations
8.
Decatris, M., Santhanam Sundar, & Kenneth J. O’Byrne. (2005). Platinum-based Chemotherapy in Metastatic Breast Cancer: The Leicester (UK) Experience. Clinical Oncology. 17(4). 249–257. 7 indexed citations
9.
Sundar, Santhanam, R.P. Symonds, M. Decatris, et al.. (2004). Phase II trial of Oxaliplatin and 5-Fluorouracil/Leucovorin combination in epithelial ovarian carcinoma relapsing within 2 years of platinum-based therapy. Gynecologic Oncology. 94(2). 502–508. 21 indexed citations
10.
Arun, C., M. Decatris, David Hemingway, N.J.M. London, & Kenneth J. O’Byrne. (2004). Endothelin-1 is a novel prognostic factor in non-small cell lung cancer. The International Journal of Biological Markers. 19(4). 262–267. 17 indexed citations
11.
Arun, C., M. Decatris, David Hemingway, N.J.M. London, & Kenneth J. O’Byrne. (2004). Endothelin-1 is a Novel Prognostic Factor in Non-Small Cell Lung Cancer. The International Journal of Biological Markers. 19(4). 262–267. 15 indexed citations
12.
Evans, T.R. Jeffry, J. C. Yao, Mary F. Mulcahy, et al.. (2004). Pegamotecan (EZ-246), a novel PEGylated camptothecin conjugate, for treatment of adenocarcinomas of the stomach and gastroesophageal (GE) junction: Preliminary results of a single-agent phase 2 study. Journal of Clinical Oncology. 22(14_suppl). 4030–4030. 6 indexed citations
13.
Evans, T.R. Jeffry, J. C. Yao, Mary F. Mulcahy, et al.. (2004). Pegamotecan (EZ-246), a novel PEGylated camptothecin conjugate, for treatment of adenocarcinomas of the stomach and gastroesophageal (GE) junction: Preliminary results of a single-agent phase 2 study. Journal of Clinical Oncology. 22(14_suppl). 4030–4030. 5 indexed citations
14.
Decatris, M., Santhanam Sundar, & Kenneth J. O’Byrne. (2003). Platinum-based chemotherapy in metastatic breast cancer: current status. Cancer Treatment Reviews. 30(1). 53–81. 170 indexed citations
15.
Sharma, Ricky A., M. Decatris, Santhanam Sundar, et al.. (2003). Reversibility of liver failure secondary to metastatic breast cancer by vinorelbine and cisplatin chemotherapy. Cancer Chemotherapy and Pharmacology. 52(5). 367–370. 13 indexed citations
16.
Decatris, M., et al.. (2002). Potential of Interferon-?? in Solid Tumours. BioDrugs. 16(4). 261–281. 42 indexed citations
17.
O’Byrne, Kenneth J., Anne Thomas, Ricky A. Sharma, et al.. (2002). A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer. British Journal of Cancer. 87(1). 15–20. 57 indexed citations
18.
Sundar, Santhanam, et al.. (2002). Potential of Interferon-?? in Solid Tumours. BioDrugs. 16(5). 349–372. 31 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Joosens Breakdown of academic impact, for papers by Katsuyuki Kunieda Breakdown of academic impact, for papers by Chris R. Garrett Breakdown of academic impact, for papers by Masaharu Ohgaki Breakdown of academic impact, for papers by Marianna Silletta Breakdown of academic impact, for papers by Shigehiko Nishimura Breakdown of academic impact, for papers by Joan Sorich Breakdown of academic impact, for papers by Enrique Grande Pulido Breakdown of academic impact, for papers by Sashidhar Yeluri Breakdown of academic impact, for papers by Thierry Nguyen
Rankless by CCL
2026